Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04337697 · ClinicalTrials.gov registry record
Neonatal Seizure Registry - Developmental Functional EValuation
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 188
- Enrollment target
NCT04337697 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 188 participants.
The verdict
NCT04337697 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 188 participants
- Enrollment target
Study Summary
The NSR-DEV study is a longitudinal cohort study of around 280 Neonatal Seizure Registry participants that aims to evaluate childhood outcomes after acute symptomatic neonatal seizures, as well as examine risk factors for developmental disabilities and whether these are modified by parent well-being.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 188 participants |
| Start Date | 2020-03-15 |
| Est. Completion | 2025-03-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04337697
The ClinicalTrials.gov registry entry for NCT04337697 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 188 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04337697 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04337697 about?
NCT04337697 is a clinical study titled "Neonatal Seizure Registry - Developmental Functional EValuation". The NSR-DEV study is a longitudinal cohort study of around 280 Neonatal Seizure Registry participants that aims to evaluate childhood outcomes after acute symptomatic neonatal seizures, as well as examine risk factors for developmental disabilities and whether these are modified by parent well-being...
What is the current status of trial NCT04337697?
This trial is currently completed. The enrollment target is 188 participants. The study started on 2020-03-15. Estimated completion is 2025-03-01.
Who is sponsoring clinical trial NCT04337697?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.